Tue, November 6, 2012
Mon, November 5, 2012
Sat, November 3, 2012
Fri, November 2, 2012
Thu, November 1, 2012
Wed, October 31, 2012
Tue, October 30, 2012
Mon, October 29, 2012
Sun, October 28, 2012
Fri, October 26, 2012
Thu, October 25, 2012
Wed, October 24, 2012
Tue, October 23, 2012
Mon, October 22, 2012
Sun, October 21, 2012
Sat, October 20, 2012
Fri, October 19, 2012
Thu, October 18, 2012
Wed, October 17, 2012
Tue, October 16, 2012
Mon, October 15, 2012
Sun, October 14, 2012
Fri, October 12, 2012
Thu, October 11, 2012

Due Diligence Complete Prior to Closing $7MM Perpetual License Sale


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. prior-to-closing-7mm-perpetual-license-sale.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

Update to Medisafe 1 Technologies Corp.SHAREHOLDERS: Due Diligence Complete Prior to Closing $7MM... -- JERUSALEM, October 24, 2012 /PRNewswire/ --

JERUSALEM, October 24, 2012 /PRNewswire/ --

Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that due diligence by both parties to the sale has been successfully completed, and the sale is expected to be finalized and initiated by November 5 2012.

The agreement will transfer rights for the full commercialization, marketing and distribution of its patented medicinal locking mechanism and bar-code matching system to a third party.  Terms of the sale include a $7MM payment to Medisafe 1 Technologies.  

About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle.  Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.  Medisafe 1 Technologies Corp. public filings may be viewed at [ http://www.sec.gov ].

Contact:
Jacob Elhadad, CEO
+972-524440000
[ Jacob.elhadad10@gmail.com ]


SOURCE Medisafe 1 Technologies Corp.




Publication Contributing Sources